Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Uddin, Shahab  [Clear All Filters]
2024
Bhat GRasool, Sethi I, Sadida HQ, Rah B, Mir R, Algehainy N, Albalawi IAltedlawi, Masoodi T, Subbaraj GKumar, Jamal F, et al. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. Cancer Metastasis Rev. 2024.
Khan AQ, Hasan A, Mir SS, Rashid K, Uddin S, Stienhoff M. Exploiting Transcription Factors to Target EMT and Cancer Stem Cells for Tumor Modulation and Therapy. Semin Cancer Biol. 2024.
Poodineh J, Akhlaghpour A, Ghaedrahmati F, Pour FKhojasteh, Uddin S, Farzaneh M, Azizidoost S. Insights into the Biological Properties of Prostate Cancer Stem Cells: Implications for Cancer Progression and Therapy. Curr Stem Cell Res Ther. 2024.
2023
Almaghrbi H, Elkardawy R, S Kumar U, Kuttikrishnan S, Abunada T, Kashyap MKumar, Ahmad A, Uddin S, C Doss GPriya, Zayed H. Analysis of signaling cascades from myeloma cells treated with pristimerin. Adv Protein Chem Struct Biol. 2023;134:147-174.
Alsayed RKhaled ME, Sheikhan KSultan AM, Alam MAli, Buddenkotte J, Steinhoff M, Uddin S, Ahmad A. Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions. Semin Cancer Biol. 2023.
Naeem A, Prakash R, Kumari N, Khan MAli, Khan AQuaiyoom, Uddin S, Verma S, Robertson AAb, Boltze J, Raza SShadab. MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease. Brain Behav Immun. 2023.
Shoaib S, Khan FBadrealam, Alsharif MA, M Malik S, Ahmed SA, Jamous YF, Uddin S, Tan CSiang, Ardianto C, Tufail S, et al. Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers. Cancers (Basel). 2023;15(8).
Waseem A, Khan AQuaiyoom, Khan MAli, Khan R, Uddin S, Boltze J, Raza SShadab. Unveiling the Therapeutic Potential of Non-coding RNAs in Stroke-Induced Tissue Regeneration. Stem Cells. 2023.
2022
Sher G, Masoodi T, Patil K, Akhtar S, Kuttikrishnan S, Ahmad A, Uddin S. Dysregulated FOXM1 Signaling in the regulation of cancer stem cells. Semin Cancer Biol. 2022.
Therachiyil L, Hussein OJ, Uddin S, Korashy HM. Regulation of the Aryl Hydrocarbon Receptor in Cancer and Cancer Stem Cells of Gynecological Malignancies: An Update on Signaling Pathways. Semin Cancer Biol. 2022.
Nasrolahi A, Azizidoost S, Radoszkiewicz K, Najafi S, Ghaedrahmati F, Anbiyaee O, Khoshnam SEsmaeil, Farzaneh M, Uddin S. Signaling pathways governing glioma cancer stem cells behavior. Cell Signal. 2022:110493.
2021
Khan AQ, Al-Tamimi M, Uddin S, Steinhoff M. F-box proteins in cancer stemness: an emerging prognostic and therapeutic target. Drug Discov Today. 2021.
Khan AQ, Rashid K, AlAmodi AA, Agha MVictor, Akhtar S, Hakeem I, Raza SShadab, Uddin S. Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids. Biomed Pharmacother. 2021;143:112142.
2020
Akhtar S, Hourani S, Therachiyil L, Al-Dhfyan A, Agouni A, Zeidan A, Uddin S, Korashy HM. Epigenetic Regulations of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway. Semin Cancer Biol. 2020.
Khan AQ, Ahmad F, Raza SShadab, Zarif L, Siveen KS, Sher G, Agha MVictor, Rashid K, Kulinski M, Buddenkotte J, et al. Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases. Semin Cancer Biol. 2020.